Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population

The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk

(2011) M. C. Amato et al.   HUMAN REPRODUCTION

Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 Diabetes

(2011) Mohammadreza Bozorgmanesh et al.   Lipids in Health and Disease

Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk

(2010) M. C. Amato et al.   DIABETES CARE

Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1

(2010) Salvatore Petta et al.   HEPATOLOGY

Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity

(2010) Roger H. Unger et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Abdominal Subcutaneous Adipose Tissue: A Protective Fat Depot?

(2009) S. A. Porter et al.   DIABETES CARE

Visceral obesity and the heart

(2008) Patrick Mathieu et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY